Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT03733002
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT03733002
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03733002. Randomized; double masking; primary purpose treatment. Start 2018-12-01 (anticipated); primary completion 2019-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke.
- Acronym
- AGNH2018
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- AngongNiuhuang pill
- Intervention (Drug)
- Placebo of AngongNiuhuang pill
- Intervention (Other)
- Standard treatment
- Lead sponsor
- Peking Union Medical College Hospital
- Collaborator
- China-Japan Friendship Hospital
- Collaborator
- Cangzhou Central Hospital
- Collaborator
- The Second Hospital of Hebei Medical University
- Collaborator
- Affiliated Hospital of Chengde Medical University
Record details
- Record id
cardio:ct-nct03733002- Content hash
7177ac31756eaf487dc97e6db60fe71d05b2ce3c3ef4cbe45f9d5b0cd01a635f